- Home
- POAS vs CNTX Comparison
POAS vs CNTX Comparison
Compare POAS & CNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$3.66
HOLD
Current Price
$1.05
Company Overview
Basic Information| Metric | POAS | CNTX |
|---|---|---|
| Founded | 2017 | 2015 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 114.0M | 102.9M |
| IPO Year | 2025 | 2021 |
Fundamental Metrics
Financial Performance| Metric | POAS | CNTX |
|---|---|---|
| Price | $3.66 | $1.05 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $5.40 |
| AVG Volume (30 Days) | ★ 499.9K | 485.5K |
| Earning Date | 01-01-0001 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $128,328.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.98 | $0.49 |
| 52 Week High | $4.30 | $1.61 |
Technical Indicators
Market Signals| Indicator | POAS | CNTX |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 43.47 |
| Support Level | N/A | $0.99 |
| Resistance Level | N/A | $1.10 |
| Average True Range (ATR) | 0.00 | 0.08 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 0.00 | 24.37 |
Price Performance
Historical Comparison POAS
CNTX
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.